Concepedia

Stellanie Krimm

SK

Statistics

Publications

7

Citations

851

H-Index

7

Active since

2013

Affiliations

Pfizer (United States)(Current)

Sutro Biopharma (United States)

University of California, San Francisco

Stellanie Krimm is an author at Pfizer (United States) specializing in pharmacology, pharmacy, and antibody-drug conjugates.

ORCID

Publications per year

2013–2025

7

Publications

7

Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates

Pavel Strop, Shu‐Hui Liu, Magdalena Dorywalska et al. · Chemistry & Biology · 2013 · 498 citations

, , +16

Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates

Magdalena Dorywalska, Pavel Strop, Jody A. Melton-Witt et al. · Bioconjugate Chemistry · 2015 · 148 citations

, , +17

Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers

Xiaofan Li, Sihong Zhou, Cristina L. Abrahams et al. · Molecular Cancer Therapeutics · 2022 · 63 citations · Full text

, , +17

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001

Cristina L. Abrahams, Xiaofan Li, Millicent Embry et al. · Oncotarget · 2018 · 52 citations · Full text

, , +17

IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control

Béatrice Bréart, Katherine Williams, Stellanie Krimm et al. · Nature · 2025 · 44 citations

, , +12

1–5 of 7